(Q39522931)

English

Combination of ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, and cisplatin enhances the inhibition of growth of human ovarian cancers

scientific article published on 17 June 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Combination of ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, and cisplatin enhances the inhibition of growth of human ovarian cancers (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1 reference

ChEBI release 2020-05-28

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Yoshihito Yokoyama

1

object named as

Yoshihito Yokoyama

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Hideki Mizunuma

4

object named as

Hideki Mizunuma

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

author name string

Bing Xin

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Tatsuhiko Shigeto

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

publication date

17 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

137

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1219-1228

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0993-1

21 January 2018

Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0993-1

21 January 2018

Peroxisome proliferator-activated receptor gamma regulates E-cadherin expression and inhibits growth and invasion of prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0993-1

21 January 2018

Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0993-1

21 January 2018

Cancer of the ovary

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0993-1

21 January 2018

IL-1beta-dependent activation of NF-kappaB mediates PGE2 release via the expression of cyclooxygenase-2 and microsomal prostaglandin E synthase.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0993-1

21 January 2018

Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0993-1

21 January 2018

Ganciclovir augments the lytic induction and apoptosis induced by chemotherapeutic agents in an Epstein-Barr virus-infected gastric carcinoma cell line

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0993-1

21 January 2018

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0993-1

21 January 2018

Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0993-1

21 January 2018

Expression of glutathione S-transferase-pi in human ovarian cancer as an indicator of resistance to chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0993-1

21 January 2018

Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0993-1

21 January 2018

Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0993-1

21 January 2018

Ovarian epithelial cancer: a role for PGE2-synthesis and signalling in malignant transformation and progression

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0993-1

21 January 2018

Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0993-1

21 January 2018

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0993-1

21 January 2018

Carbonyl reductase as a significant predictor of survival and lymph node metastasis in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0993-1

21 January 2018

Prostaglandins and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0993-1

21 January 2018

Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0993-1

21 January 2018

Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0993-1

21 January 2018

Peroxisome proliferator-activated receptor delta and gamma agonists differentially alter tumor differentiation and progression during mammary carcinogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0993-1

21 January 2018

Clofibric acid, a peroxisome proliferator-activated receptor alpha ligand, inhibits growth of human ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0993-1

21 January 2018

Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21681689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostaglandin and thromboxane production in ovarian cancer tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/21681689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21681689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differentiation and reversal of malignant changes in colon cancer through PPARgamma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21681689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peroxisome proliferator-activated receptor modulators as potential chemopreventive agents.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21681689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21681689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of cytoreductive surgery with pelvic and paraaortic lymphadenectomy and intermittent cisplatin-based combination chemotherapy for improvement of long-term survival in ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21681689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostacyclin and thromboxane in ovarian cancer: Effect of cytostatics and prostaglandin synthesis inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/21681689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Moderate levels of ethanol induce expression of vascular endothelial growth factor and stimulate angiogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21681689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor gamma in epithelial ovarian tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/21681689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/21681689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peroxisome proliferator-activated receptor gamma and cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/21681689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of cyclooxygenase-2 and its relationship to p53 accumulation in ovarian adenocarcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/21681689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00432-011-0993-1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39522931&oldid=2202949167"